Issue 8, 2024

A monofunctional Pt(ii) complex combats triple negative breast cancer by triggering lysosome-dependent cell death

Abstract

Monofunctional Pt(II) complexes with potent efficacy to overcome the drawbacks of current platinum drugs represent a promising therapeutic approach for triple negative breast cancer (TNBC). A heterocyclic-ligated monofunctional Pt(II) complex PtL with a unique action of mode was designed and investigated. PtL induced DNA single-strand breaks and caused genomic instability in TNBC cells. Mechanism studies demonstrated that PtL disrupted lysosomal acidity and function, which in turn triggered lysosome-dependent cell death. Furthermore, PtL showed convincing suppression in the tube forming and cell migratory abilities against the metastatic potential of TNBC cells. The synthesis and investigation of PtL revealed its potential value as an anti-TNBC drug and extended the family of monofunctional Pt(II) complexes.

Graphical abstract: A monofunctional Pt(ii) complex combats triple negative breast cancer by triggering lysosome-dependent cell death

Supplementary files

Article information

Article type
Paper
Submitted
27 Okt. 2023
Accepted
11 Janv. 2024
First published
24 Janv. 2024

Dalton Trans., 2024,53, 3808-3817

A monofunctional Pt(II) complex combats triple negative breast cancer by triggering lysosome-dependent cell death

X. Shen, Y. Peng, Z. Yang, R. Li, H. Zhou, X. Ye, Z. Han and X. Shi, Dalton Trans., 2024, 53, 3808 DOI: 10.1039/D3DT03598K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements